Cargando…
Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
INTRODUCTION: Given the current lack of an approved and effective treatment or vaccine for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), repositioning old drugs for use as an antiviral treatment is an interesting strategy because knowledge about these drugs’ safety profile, posology,...
Autores principales: | Shetty, Rajesh M, Namachivayam, ArunKumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138637/ https://www.ncbi.nlm.nih.gov/pubmed/34045812 http://dx.doi.org/10.5005/jp-journals-10071-23773 |
Ejemplares similares
-
Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020) -
Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020) -
Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
por: Zou, Li, et al.
Publicado: (2020) -
Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021) -
Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
por: Singh, Bhagteshwar, et al.
Publicado: (2021)